3 December 2015
James Boyce – Director of Communications and Government Relations at Medicines Australia will speak about valuing the innovative medicines industry: a year of political challenges and the work ahead to change perceptions in Australia.
3 December 2015
18 September 2015
Dr Saxon Smith – President, AMA (NSW) Board of Directors will be speaking about his passion for public health and patient advocacy. He will also provide a perspective on the AMA’s vision for modern Australian healthcare as well as discuss the role of the pharmaceutical industry in improving the lives of Australian patients.
11 June 2015
Tim James (CEO of Medicines Australia)
Medicines Australia and its Strategic Priorities
5 March 2015
Mendel Grobler (Director – Strategic Access and Policy, Pfizer)
The Pharmaceutical Benefits Scheme: Bent, overspent or just spent?
4 December 2014
Mr Peter Stephenson (Multichannel Marketing Manager @ MSD) will be speaking about how new digital technologies are reinventing healthcare as healthcare professionals and patients increasingly embrace digital technologies.
Annual General Meeting and election of APPA Committee.
20 August 2014
Geoff McDonald (General Manager, GSK) and Deborah Monk (Compliance Director, Medicines Australia) will be speaking about the revised Medicines Australia’s Code on Conduct, including Transparency and the reporting of payments to healthcare professionals.
22 May 2014
Ms. Catherine King, Shadow Health Minister, will be speaking on major issues in the federal health portfolio, specifically the Pharmaceutical Benefit Scheme; as well as responding to any proposed changes to health policy that may be announced in the May budget.
10 February 2014
Dr. Martin Cross, Chair of Medicines Australia will be speaking about the future of the Australian pharmaceutical industry and some of the many challenges facing the industry.
24 July 2013
Dr Dominic Barnes, Vice President and General Manager of Shire Australia will be speaking about transparency of payments and transfers of value between healthcare professionals and the industry. Where do we need to go?
22 April 2013
Dr Glenn Carter, Managing Director of Pharmaceutical & Medical Professionals will be speaking about workforce trends in the pharmaceutical industry; and Dr Gary Jankelowitz of MSD Australia will be discussing PBS advocacy and scientific leader in hepatitis